These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7505056)

  • 1. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study.
    Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP
    Prostate; 1993; 23(4):329-36. PubMed ID: 7505056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues.
    Ibrahim GK; MacDonald JA; Kerns BJ; Ibrahim SN; Humphrey PA; Robertson CN
    Surg Oncol; 1992 Apr; 1(2):151-5. PubMed ID: 1285216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.
    Gu K; Mes-Masson AM; Gauthier J; Saad F
    Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
    Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
    Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
    Hasby EA; Saied EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates.
    Giri DK; Pal R; Wadhwa SN; Talwar GP
    Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.
    Ibrahim GK; Kerns BJ; MacDonald JA; Ibrahim SN; Kinney RB; Humphrey PA; Robertson CN
    J Urol; 1993 Jan; 149(1):170-3. PubMed ID: 7678041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study of c-erbB-2 proto-oncogene product in prostatic cancer].
    Kokuho M; Yoshiki T; Hamaguchi A; Okada Y; Tomoyoshi T; Higuchi K
    Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1872-8. PubMed ID: 7902885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases.
    Hanna W; Kahn HJ; Andrulis I; Pawson T
    Mod Pathol; 1990 Jul; 3(4):455-61. PubMed ID: 1977159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues.
    Tsutsumi Y; Naber SP; DeLellis RA; Wolfe HJ; Marks PJ; McKenzie SJ; Yin S
    Hum Pathol; 1990 Jul; 21(7):750-8. PubMed ID: 1972932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of neu/c-erbB-2 in human brain tumors.
    Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
    Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
    Lee EY; Cibull ML; Strodel WE; Haley JV
    Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.
    Sadasivan R; Morgan R; Jennings S; Austenfeld M; Van Veldhuizen P; Stephens R; Noble M
    J Urol; 1993 Jul; 150(1):126-31. PubMed ID: 7685420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.
    Cohen JA; Weiner DB; More KF; Kokai Y; Williams WV; Maguire HC; LiVolsi VA; Greene MI
    Oncogene; 1989 Jan; 4(1):81-8. PubMed ID: 2563577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-erbB-2 oncoprotein immunostaining in serous effusions.
    Ascoli V; Scalzo CC; Nardi F
    Cytopathology; 1993; 4(4):207-18. PubMed ID: 8104524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR.
    Schwartz S; Caceres C; Morote J; De Torres I; Rodriguez-Vallejo JM; Gonzalez J; Reventos J
    Int J Cancer; 1998 May; 76(4):464-7. PubMed ID: 9590118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.